MedTrace Logo

Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA

NCT03776903 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2018-12-17

No results posted yet for this study

Summary

The purpose of this study is to evaluate the performance of the ZIKV Detect™ 2.0 IgM Capture ELISA using archived confirmed ZIKV positive and confirmed ZIKV negative human serum samples.

Conditions

  • Zika Virus Infection

Interventions

OTHER

ZIKV Detect™ 2.0 IgM Capture ELISA

De-identified archive specimens are tested by ELISA and compared to reference testing (RT-PCR and CDC MAC-ELISA)

Sponsors & Collaborators

Principal Investigators

  • Frances Chu, PhD · InBios International

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2018-08-31
Completion
2018-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03776903 on ClinicalTrials.gov